undamentalytics Newsletter

Transmedics Group, Inc. balance sheet

At the end of fiscal 2025, Transmedics Group, Inc. had total assets of $1.07bn, total liabilities of $595m and shareholders' equity of $473m. It held $489m in cash against $463m of debt: net cash of $26.1m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Transmedics Group, Inc.: balance sheet, annual
Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents20212526201395337489491
Receivables377628649884104
Inventory91112152144474954
Total current assets35100147119252511497638651
Goodwill—————12121212
Total assets421051521352777068041,0681,464
Accounts payable5717313101013
Deferred revenue (current)000002233
Total current liabilities131612232455608998
Short-term debt———————1020
Long-term debt3434353559————
Total debt3534353560447450463474
Total liabilities4851486790569575595946
Shareholders' equity−1925510468187137229473518
Non-controlling interests and other (assets − liabilities − equity)187————————
Net debt (negative = net cash)15141010−14152113−26−17
Shares outstanding14m—27m28m32m33m34m34m35m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: GKOS vs TMDXNVCR vs TMDXBVS vs TMDXATRC vs TMDX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Transmedics Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Transmedics Group, Inc.